Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Endava Analyst Ratings and Price Targets | NYSE:DAVA | Benzinga
Endava PLC has a consensus price target of $37.72 based on the ratings of 15 analysts. The high is $90 issued by Cowen & Co. on February 15, 2023. The low is $17 issued by Morgan Stanley on May 15, 2025. The 3 most-recent analyst ratings were released by Guggenheim, Needham, and Susquehanna on June 10, 2025, June 10, 2025, and May 20, 2025, respectively. With an average price target of $29 between Guggenheim, Needham, and Susquehanna, there's an implied 111.99% upside for Endava PLC from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Guggenheim
Needham
Susquehanna
JP Morgan
Morgan Stanley
1calculated from analyst ratings
Analyst Ratings for Endava
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/10/2025 | Buy Now | 82.75% | Guggenheim | Jonathan Lee | $25 → $25 | Reiterates | Buy → Buy | Get Alert |
| 06/10/2025 | Buy Now | 46.2% | Needham | Mayank Tandon | $18 → $20 | Maintains | Buy | Get Alert |
| 05/20/2025 | Buy Now | 207.02% | Susquehanna | James Friedman | $50 → $42 | Maintains | Positive | Get Alert |
| 05/19/2025 | Buy Now | 31.58% | JP Morgan | Puneet Jain | → $18 | Downgrade | Overweight → Neutral | Get Alert |
| 05/15/2025 | Buy Now | 82.75% | Guggenheim | Jonathan Lee | $28 → $25 | Maintains | Buy | Get Alert |
| 05/15/2025 | Buy Now | 24.27% | Morgan Stanley | James Faucette | $33 → $17 | Maintains | Equal-Weight | Get Alert |
| 05/15/2025 | Buy Now | 31.58% | Needham | Mayank Tandon | $22 → $18 | Maintains | Buy | Get Alert |
| 05/13/2025 | Buy Now | 104.68% | Guggenheim | Jonathan Lee | $40 → $28 | Maintains | Buy | Get Alert |
| 02/21/2025 | Buy Now | 265.5% | Susquehanna | James Friedman | $55 → $50 | Maintains | Positive | Get Alert |
| 02/21/2025 | Buy Now | 177.78% | Needham | Mayank Tandon | $43 → $38 | Maintains | Buy | Get Alert |
| 01/31/2025 | Buy Now | 155.85% | Morgan Stanley | James Faucette | $33 → $35 | Maintains | Equal-Weight | Get Alert |
| 01/10/2025 | Buy Now | 214.33% | Needham | Mayank Tandon | $36 → $43 | Maintains | Buy | Get Alert |
| 11/22/2024 | Buy Now | 111.99% | B of A Securities | Tyler DuPont | → $29 | Initiates | → Neutral | Get Alert |
| 11/14/2024 | Buy Now | 163.16% | Needham | Mayank Tandon | $33 → $36 | Maintains | Buy | Get Alert |
| 11/13/2024 | Buy Now | 163.16% | TD Cowen | Bryan Bergin | $35 → $36 | Maintains | Buy | Get Alert |
| 11/06/2024 | Buy Now | 192.4% | Guggenheim | Jonathan Lee | $45 → $40 | Maintains | Buy | Get Alert |
| 10/28/2024 | Buy Now | 97.37% | Citigroup | Ashwin Shirvaikar | $30 → $27 | Maintains | Neutral | Get Alert |
| 09/20/2024 | Buy Now | 302.05% | Susquehanna | James Friedman | $66 → $55 | Maintains | Positive | Get Alert |
| 09/20/2024 | Buy Now | 141.23% | Needham | Mayank Tandon | $42 → $33 | Maintains | Buy | Get Alert |
| 09/16/2024 | Buy Now | 228.95% | Guggenheim | Jonathan Lee | $55 → $45 | Maintains | Buy | Get Alert |
| 09/06/2024 | Buy Now | 243.57% | JP Morgan | Puneet Jain | $41 → $47 | Maintains | Overweight | Get Alert |
| 05/24/2024 | Buy Now | 302.05% | Guggenheim | Jonathan Lee | $60 → $55 | Maintains | Buy | Get Alert |
| 05/24/2024 | Buy Now | 199.71% | JP Morgan | Puneet Jain | $43 → $41 | Maintains | Overweight | Get Alert |
| 05/24/2024 | Buy Now | 207.02% | TD Cowen | Bryan Bergin | $46 → $42 | Maintains | Buy | Get Alert |
| 05/24/2024 | Buy Now | 141.96% | Redburn Atlantic | Harry Read | → $33.1 | Initiates | → Neutral | Get Alert |
| 05/24/2024 | Buy Now | 207.02% | Needham | Mayank Tandon | $50 → $42 | Maintains | Buy | Get Alert |
| 05/23/2024 | Buy Now | 265.5% | Wedbush | Moshe Katri | $65 → $50 | Maintains | Outperform | Get Alert |
| 05/02/2024 | Buy Now | 214.33% | JP Morgan | Tien-Tsin Huang | $49 → $43 | Maintains | Overweight | Get Alert |
| 05/01/2024 | Buy Now | 228.95% | HSBC | Phani Kanumuri | → $45 | Upgrade | Hold → Buy | Get Alert |
| 04/22/2024 | Buy Now | 192.4% | Morgan Stanley | James Faucette | → $40 | Maintains | Equal-Weight | Get Alert |
| 04/22/2024 | Buy Now | 141.23% | Citigroup | Ashwin Shirvaikar | $40 → $33 | Maintains | Neutral | Get Alert |
| 03/19/2024 | Buy Now | 258.19% | JP Morgan | Puneet Jain | → $49 | Upgrade | Neutral → Overweight | Get Alert |
| 03/19/2024 | Buy Now | 338.6% | Guggenheim | Jonathan Lee | → $60 | Initiates | → Buy | Get Alert |
| 03/12/2024 | Buy Now | 265.5% | Needham | Mayank Tandon | $50 → $50 | Reiterates | Buy → Buy | Get Alert |
| 03/12/2024 | Buy Now | 382.46% | Susquehanna | James Friedman | $83 → $66 | Maintains | Positive | Get Alert |
| 03/01/2024 | Buy Now | 192.4% | Citigroup | Ashwin Shirvaikar | $90 → $40 | Downgrade | Buy → Neutral | Get Alert |
| 03/01/2024 | Buy Now | 280.12% | TD Cowen | Bryan Bergin | $85 → $52 | Maintains | Outperform | Get Alert |
| 03/01/2024 | Buy Now | 258.19% | JP Morgan | Puneet Jain | $79 → $49 | Maintains | Neutral | Get Alert |
| 03/01/2024 | Buy Now | 265.5% | Needham | Mayank Tandon | $70 → $50 | Maintains | Buy | Get Alert |
| 02/14/2024 | Buy Now | 477.49% | JP Morgan | Puneet Jain | $77 → $79 | Maintains | Neutral | Get Alert |
| 01/24/2024 | Buy Now | 484.8% | Morgan Stanley | James Faucette | $68 → $80 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 01/17/2024 | Buy Now | 557.89% | Citigroup | Ashwin Shirvaikar | $70 → $90 | Maintains | Buy | Get Alert |
| 01/08/2024 | Buy Now | 484.8% | HSBC | Phani Kanumuri | $68 → $80 | Downgrade | Buy → Hold | Get Alert |
| 12/08/2023 | Buy Now | 462.87% | JP Morgan | Puneet Jain | → $77 | Initiates | → Neutral | Get Alert |
| 11/16/2023 | Buy Now | 411.7% | Needham | Mayank Tandon | $65 → $70 | Maintains | Buy | Get Alert |
| 10/02/2023 | Buy Now | 506.73% | Susquehanna | James Friedman | $100 → $83 | Maintains | Positive | Get Alert |
| 09/20/2023 | Buy Now | 411.7% | TD Cowen | Bryan Bergin | $78 → $70 | Maintains | Outperform | Get Alert |
| 09/20/2023 | Buy Now | 397.08% | Morgan Stanley | James Faucette | $72 → $68 | Maintains | Overweight | Get Alert |
| 09/20/2023 | Buy Now | 375.15% | Needham | Mayank Tandon | $68 → $65 | Maintains | Buy | Get Alert |
| 09/14/2023 | Buy Now | 426.32% | Morgan Stanley | James Faucette | $70 → $72 | Maintains | Overweight | Get Alert |
| 07/24/2023 | Buy Now | 411.7% | Morgan Stanley | James Faucette | $70 → $70 | Reiterates | Overweight → Overweight | Get Alert |
| 07/17/2023 | Buy Now | 411.7% | Morgan Stanley | James Faucette | $70 → $70 | Reiterates | Overweight → Overweight | Get Alert |
| 07/17/2023 | Buy Now | 440.94% | HSBC | Phani Kanumuri | → $74 | Initiates | → Buy | Get Alert |
| 06/26/2023 | Buy Now | 411.7% | Morgan Stanley | James Faucette | $70 → $70 | Reiterates | Overweight → Overweight | Get Alert |
| 06/20/2023 | Buy Now | 411.7% | Morgan Stanley | James Faucette | → $70 | Reiterates | Overweight → Overweight | Get Alert |
| 06/12/2023 | Buy Now | 411.7% | Morgan Stanley | James Faucette | → $70 | Reiterates | → Overweight | Get Alert |
| 06/12/2023 | Buy Now | 630.99% | Susquehanna | James Friedman | $104 → $100 | Maintains | Positive | Get Alert |
| 06/12/2023 | Buy Now | 382.46% | TD Cowen | Bryan Bergin | $76 → $66 | Maintains | Outperform | Get Alert |
| 06/05/2023 | Buy Now | 397.08% | Needham | Mayank Tandon | → $68 | Reiterates | Buy → Buy | Get Alert |
| 05/24/2023 | Buy Now | 287.43% | Deutsche Bank | Bryan Keane | $78 → $53 | Maintains | Hold | Get Alert |
| 05/24/2023 | Buy Now | 411.7% | Morgan Stanley | James Faucette | $95 → $70 | Maintains | Overweight | Get Alert |
| 05/24/2023 | Buy Now | 660.23% | Susquehanna | James Friedman | $112 → $104 | Maintains | Positive | Get Alert |
| 05/24/2023 | Buy Now | 397.08% | Needham | Mayank Tandon | $90 → $68 | Maintains | Buy | Get Alert |
| 05/19/2023 | Buy Now | 594.44% | Morgan Stanley | James Faucette | $105 → $95 | Maintains | Overweight | Get Alert |
| 05/01/2023 | Buy Now | 521.35% | Citigroup | Ashwin Shirvaikar | $95 → $85 | Maintains | Buy | Get Alert |
| 04/20/2023 | Buy Now | 718.71% | Susquehanna | James Friedman | $120 → $112 | Maintains | Positive | Get Alert |
| 02/16/2023 | Buy Now | 594.44% | Citigroup | Ashwin Shirvaikar | $105 → $95 | Maintains | Buy | Get Alert |
| 02/15/2023 | Buy Now | 667.54% | Morgan Stanley | James Faucette | $110 → $105 | Maintains | Overweight | Get Alert |
| 02/15/2023 | Buy Now | 557.89% | Cowen & Co. | Bryan Bergin | $95 → $90 | Maintains | Outperform | Get Alert |
| 02/15/2023 | Buy Now | 557.89% | Needham | Mayank Tandon | $100 → $90 | Maintains | Buy | Get Alert |
| 01/27/2023 | Buy Now | 704.09% | Morgan Stanley | James Faucette | $95 → $110 | Maintains | Overweight | Get Alert |
| 11/21/2022 | Buy Now | 667.54% | Citigroup | Ashwin Shirvaikar | $110 → $105 | Maintains | Buy | Get Alert |
| 11/16/2022 | Buy Now | 777.19% | Susquehanna | James Friedman | $110 → $120 | Maintains | Positive | Get Alert |
| 11/16/2022 | Buy Now | 630.99% | Needham | Mayank Tandon | $112 → $100 | Maintains | Buy | Get Alert |
| 09/28/2022 | Buy Now | 470.18% | Deutsche Bank | Bryan Keane | $94 → $78 | Maintains | Hold | Get Alert |
| 09/28/2022 | Buy Now | 557.89% | Wedbush | Moshe Katri | $120 → $90 | Maintains | Outperform | Get Alert |
| 09/28/2022 | Buy Now | 704.09% | Susquehanna | James Friedman | $150 → $110 | Maintains | Positive | Get Alert |
| 09/28/2022 | Buy Now | 594.44% | Morgan Stanley | James Faucette | $130 → $95 | Maintains | Overweight | Get Alert |
| 09/28/2022 | Buy Now | 704.09% | Citigroup | Ashwin Shirvaikar | $145 → $110 | Maintains | Buy | Get Alert |
| 09/27/2022 | Buy Now | 718.71% | Needham | Mayank Tandon | $135 → $112 | Maintains | Buy | Get Alert |
| 09/13/2022 | Buy Now | — | Keybanc | Thomas Blakey | — | Initiates | → Sector Weight | Get Alert |
FAQ
What is the target price for Endava (DAVA) stock?
The latest price target for Endava (NYSE:DAVA) was reported by Guggenheim on June 10, 2025. The analyst firm set a price target for $25.00 expecting DAVA to rise to within 12 months (a possible 82.75% upside). 21 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Endava (DAVA)?
The latest analyst rating for Endava (NYSE:DAVA) was provided by Guggenheim, and Endava reiterated their buy rating.
When was the last upgrade for Endava (DAVA)?
The last upgrade for Endava PLC happened on May 1, 2024 when HSBC raised their price target to $45. HSBC previously had a hold for Endava PLC.
When was the last downgrade for Endava (DAVA)?
The last downgrade for Endava PLC happened on May 19, 2025 when JP Morgan changed their price target from N/A to $18 for Endava PLC.
When is the next analyst rating going to be posted or updated for Endava (DAVA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Endava, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Endava was filed on June 10, 2025 so you should expect the next rating to be made available sometime around June 10, 2026.
Is the Analyst Rating Endava (DAVA) correct?
While ratings are subjective and will change, the latest Endava (DAVA) rating was a reiterated with a price target of $25.00 to $25.00. The current price Endava (DAVA) is trading at is $13.68, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
